SCHEMBL164070

SCHEMBL164070

CCCCNC(=O)c1ccc(O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.64
NAAA Q02083 2/20 0.62
HDAC3 O15379 4/20 0.59
HDAC1 Q13547 4/20 0.59
HDAC2 Q92769 4/20 0.59
HDAC10 Q969S8 2/20 0.59
HDAC11 Q96DB2 2/20 0.59
HDAC8 Q9BY41 2/20 0.59
HDAC6 Q9UBN7 2/20 0.59
HDAC4 P56524 1/20 0.59
HDAC7 Q8WUI4 1/20 0.59
HDAC9 Q9UKV0 1/20 0.59
HDAC5 Q9UQL6 1/20 0.59
ESRRG P62508 2/20 0.59
MLYCD O95822 1/20 0.58
TSHR P16473 1/20 0.58
HTT P42858 1/20 0.58
ALDH1A1 P00352 1/20 0.58
CA2 P00918 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19525772 0.95 DRD2 (0.60) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL16350299 0.95 L3MBTL1 (0.73) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL337999 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL7271142 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL7263385 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL338163 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL11035322 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL338174 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL337535 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1
SCHEMBL7270311 0.93 L3MBTL1 (0.76) L3MBTL1SMN1; SMN2NAAAHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0639111-A1 ADSORPTION MATRICES KEM-EN-TEC A/S (DK) 1995-02-22 EP claimed
EP-0404039-B1 PHARMACEUTICALS CONTAINING DI-TERT.BUTYLHYDROXYPHENYL-DERIVATIVES AND NEW DERIVATIVES Roche Diagnostics GmbH (DE) 1993-01-13 EP claimed
WO-1992016292-A1 ADSORPTION MATRICES KEM-EN-TEC A/S (DK) 1992-10-01 WO claimed
US-9856210-B2 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis KYOTO UNIVERSITY (JP) 2018-01-02 US disclosed
EP-2611437-B1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS UNIV KYOTO (JP) 2017-03-29 EP disclosed
US-20130225642-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS KYOTO UNIVERSITY (JP) 2013-08-29 US disclosed
EP-2611437-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2013-07-10 EP disclosed
WO-2012029994-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS KYOTO UNIVERSITY (JP) 2012-03-08 WO disclosed
US-20110076613-A1 RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND METHOD FOR PRODUCING THE SAME, AND RELIEF PRINTING PLATE AND METHOD FOR MAKING THE SAME FUJIFILM CORPORATION (JP) 2011-03-31 US disclosed
US-20110076613-A1 RESIN COMPOSITION FOR LASER ENGRAVING, RELIEF PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND METHOD FOR PRODUCING THE SAME, AND RELIEF PRINTING PLATE AND METHOD FOR MAKING THE SAME FUJIFILM CORPORATION (JP) 2011-03-31 US disclosed
EP-0544908-B1 THERMOPLASTIC ELASTOMER COMPOSITION SUMITOMO CHEMICAL CO (JP) 1996-01-31 EP disclosed
EP-0594845-A1 AROMATIC OLIGOMER AND PRODUCTION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-05-04 EP disclosed
US-5292810-A graft polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-03-08 US disclosed
EP-0544908-A1 THERMOPLASTIC ELASTOMER COMPOSITION SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1993-06-09 EP disclosed
EP-0511385-A1 THERMOPLASTIC GRAFT COPOLYMER AND PRODUCTION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-11-04 EP disclosed
WO-1992016292-A1 ADSORPTION MATRICES KEM-EN-TEC A/S (DK) 1992-10-01 WO disclosed
EP-0345728-A2 Dye composition for keratinous fiber Kao Corporation (JP) 1989-12-13 EP disclosed
US-4230606-A Polyoxymethylene molding composition containing melamine formaldehyde polycondensate DEUTSCHE GOLD -UND SILBER-SCHEIDEARSTALT VORMALS ROESSLER (DE) 1980-10-28 US disclosed
US-4139575-A AND ANTIOXIDATION AGENT; IMPROVED THERMAL STABILITY DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) 1979-02-13 US disclosed
US-4098709-A LUBRICANTS ROHM AND HAAS COMPANY (US) 1978-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225642-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS SMN1; SMN2, SOD1, SOD3 L3MBTL1 1654/4885SMN1; SMN2 1/4885NAAA 2182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.